JohnTimothyLittleMD

PubMed

• Association Between Antipsychotics and All-Cause Mortality Among Community-Dwelling Older Adults.
  Kheirbek, R. E.,Fokar, A.,Little, J. T.,Balish, M.,Shara, N. M.,Boustani, M. A.,Llorente, M.> ;J. Gerontol. A Biol. Sci. Med. Sci.. 2019 Feb 13
• 3 citations
  Prevalence of Mental Health Disorders in Geriatric U.S. Military Veterans.
  John T. Little> ;The American Journal of Geriatric Psychiatry. 2018 Feb 7
• 3 citations
  Application of depression rating scales in patients with Parkinson's disease with and without co-Occurring anxiety
  Jessica Calleo, James Williams, Amber B. Amspoker, Leah Swearingen, Elaina S. Hirsch, Karen E. Anderson, Susanne R. Goldstein, Stephen Grill, Susan W. Lehmann, John T....> ;Journal of Parkinson's Disease. 2013 Jan 1
• 87 citations
  Prevalence of Psychotic Symptoms in a Community-Based Parkinson Disease Sample
  Joel Mack, Peter V. Rabins, Karen E. Anderson, Susanne R. Goldstein, Stephen Grill, Elaina S. Hirsch, Susan W. Lehmann, John T. Little, Russell L. Margolis, Justin Pal...> ;The American Journal of Geriatric Psychiatry. 2012 Feb 1
• 136 citations
  A phase II trial of huperzine A in mild to moderate Alzheimer disease
  Michael S. Rafii, S. Walsh, John T. Little, K. Behan, Brigid Reynolds, C. Ward, Shelia Jin, R. G. Thomas, Paul S. Aisen> ;Neurology. 2011 Apr 19
• Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease.
  Pontone, G.M., Williams, J.R., Anderson, K.E., Chase, G., Goldstein, S.A., Grill, S., Hirsch, E.S., Lehmann, S., Little, J.T., Margolis, R.L., Rabins, P.V., Weiss, H.D...> ;Mov Disord. 2009-07-15
• Splicing factor SPF30 bridges an interaction between the prespliceosome protein U2AF35 and tri-small nuclear ribonucleoprotein protein hPrp3.
  Little, J.T., Jurica, M.S.> ;J Biol Chem. 2008 Mar 28
• The transcriptional repressor dMnt is a regulator of growth in Drosophila melanogaster.
  Loo, L.M., Secombe, J., Little, J.T., Carlos, L., Yost, C., Cheng, P., Flynn, E.M., Edgar, B.A., Eisenman, R.N.> ;Mol Cell Biol. 2005 Aug
• Drug-induced regulation of the MDR1 promoter in Candida albicans.
  > ;Antimicrob Agents Chemother. 2005 Jul
• Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression.
  > ;Biol Psychiatry. 2005 Feb 1
• Regional cerebral glucose utilization in patients with a range of severities of unipolar depression.
  Kimbrell, T.A., Ketter, T.A., George, M.S., Little, J.T., Benson, B.E., Willis, M.W., Herscovitch, P., Post, R.M.> ;Biol Psychiatry. 2002 Feb 1
• Sundown syndrome in severely demented patients with probable Alzheimer's disease.
  Little, J. T., Satlin, A., Sunderland, T., Volicer, L.> ;J Geriatr Psychiatry Neurol. 1995 Apr
• Differential cholinergic regulation in Alzheimer''s patients compared to controls following chronic blockade with scopolamine: a SPECT study.
  Sunderland, T., Esposito, G., Molchan, S. E., Coppola, R., Jones, D. W., Gorey, J., Little, J. T., Bahro, M., Weinberger, D. R.> ;Psychopharmacology (Berl). 1995 Sep
• How common is resistance to treatment in recurrent, nonpsychotic geriatric depression?
  Little, J. T., Reynolds, C. F., Dew, M. A., Frank, E., Begley, A. E., Miller, M. D., Cornes, C., Mazumdar, S., Perel, J. M., Kupfer, D. J.> ;Am J Psychiatry. 1998 Aug
• The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls.
  Broocks, A., Little, J. T., Martin, A., Minichiello, M. D., Dubbert, B., Mack, C., Tune, L., Murphy, D. L., Sunderland, T.> ;Biol Psychiatry. 1998 Mar 15
• Serotonergic modulation of anticholinergic effects on cognition and behavior in elderly humans.
  Little, J. T., Broocks, A., Martin, A., Hill, J. L., Tune, L. E., Mack, C., Cantillon, M., Molchan, S., Murphy, D. L., Sunderland, T.> ;Psychopharmacology (Berl). 1995 Aug
• Fluvoxamine pharmacotherapy of anxiety disorders in later life: preliminary open-trial data.
  Wylie, M. E., Miller, M. D., Shear, M. K., Little, J. T., Mulsant, B. H., Pollock, B. G., Reynolds, C. F.> ;J Geriatr Psychiatry Neurol. 2000
• CSF thyrotropin-releasing hormone gender difference: implications for neurobiology and treatment of depression.
  Frye, M. A., Gary, K. A., Marangell, L. B., George, M. S., Callahan, A. M., Little, J. T., Huggins, T., Corá-Locatelli, G., Osuch, E. A., Winokur, A., Post, R. M.> ;J Neuropsychiatry Clin Neurosci. 1999
• A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-week outcome.
  Mulsant, B. H., Pollock, B. G., Nebes, R. D., Miller, M. D., Little, J. T., Stack, J., Houck, P. R., Bensasi, S., Mazumdar, S., Reynolds, C. F.> ;J Clin Psychiatry. 1999
• Tardive myoclonus.
  Little, J. T., Jankovic, J.> ;Mov Disord. 1987
• Cognitive effects of 1- and 20-hertz repetitive transcranial magnetic stimulation in depression: preliminary report.
  Little, J. T., Kimbrell, T. A., Wassermann, E. M., Grafman, J., Figueras, S., Dunn, R. T., Danielson, A., Repella, J., Huggins, T., George, M. S., Post, R. M.> ;Neuropsychiatry Neuropsychol Behav Neurol. 2000 Apr
• Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial.
  George, M. S., Wassermann, E. M., Kimbrell, T. A., Little, J. T., Williams, W. E., Danielson, A. L., Greenberg, B. D., Hallett, M., Post, R. M.> ;Am J Psychiatry. 1997 Dec
• Venlafaxine or bupropion responders but not nonresponders show baseline prefrontal and paralimbic hypometabolism compared with controls.
  Little, J. T., Ketter, T. A., Kimbrell, T. A., Danielson, A., Benson, B., Willis, M. W., Post, R. M.> ;Psychopharmacol Bull. 1996
• Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metab...
  Kimbrell, T. A., Little, J. T., Dunn, R. T., Frye, M. A., Greenberg, B. D., Wassermann, E. M., Repella, J. D., Danielson, A. L., Willis, M. W., Benson, B. E., Speer, A...> ;Biol Psychiatry. 1999 Dec 15
• Venlafaxine but not bupropion decreases cerebrospinal fluid 5-hydroxyindoleacetic acid in unipolar depression.
  Little, J. T., Ketter, T. A., Mathé, A. A., Frye, M. A., Luckenbaugh, D., Post, R. M.> ;Biol Psychiatry. 1999 Feb 1
• Join now to see all